An upcoming Vivo tablet has passed China’s 3C certification. This tablet appears to be the Vivo Pad 4 Pro, a flagship ...

The Vivo Pad 4 Pro is the upcoming flagship tablet from the brand, which is expected to go official next month in China ...

Vivo is expected to hold a mega launch event in China to unveil multiple products. These include the Vivo X200 Ultra, X200S, ...

Antimicrobial resistance has recently increased due to emerging carbapenem-resistant Klebsiella pneumoniae and extended-spectrum β-lactamase (ESBL)-producing strains of K. pneumoniae. Osaka ...

Unlike some of the new smartphones in the segment, the iQOO Neo 10R skips a dedicated telephoto camera. It houses a 50MP ...

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with ...

Trevi Therapeutics (NASDAQ:TRVI – Free Report) had its price target increased by HC Wainwright from $7.50 to $12.50 in a ...

PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* (NASDAQ: IINN) ...

Capital Infra Trust, an infrastructure investment trust, has raised Rs 2,363 crore through debt securities to strengthen its ...